What is von Willebrand factor? Understanding this crucial blood component

When it comes to our overall health, the importance of our blood cannot be overstated. This complex fluid is responsible for so many vital functions, including delivering oxygen and nutrients to our tissues, removing waste products, and helping to keep us healthy by fighting infections and clotting to prevent blood loss. But the blood is far more intricate than just red and white blood cells floating in plasma. There are a variety of different components at play, including the von Willebrand factor. Let’s take a closer look at what this essential protein is all about, and why it matters so much.

What Is von Willebrand Factor?

The von Willebrand factor (vWF) is a glycoprotein found in the blood that plays a key role in both hemostasis (the process of stopping bleeding) and thrombosis (the formation of blood clots within the circulatory system). This large, multimeric protein is produced by the endothelial cells in blood vessels and megakaryocytes in the bone marrow, and is stored in the Weibel-Palade bodies of endothelial cells and alpha-granules of platelets.

The Structure of vWF

The vWF molecule is incredibly complex, consisting of several domains that serve a variety of functions. The most well-known of these domains is the A1 domain, which is responsible for binding to collagen in the extracellular matrix of blood vessels, as well as to platelets at the site of an injury. In addition to the A1 domain, vWF also contains domains that bind to factor VIII, heparin, and other plasma proteins, as well as a propeptide that is cleaved during secretion to activate the mature vWF.

What Functions Does vWF Serve in the Body?

If you’ve never heard of the von Willebrand factor before, you might be wondering what it actually does in the body. The answer is that vWF serves a range of crucial functions, including:

  • Helping platelets stick together at the site of an injury
  • Protecting factor VIII from rapid destruction
  • Binding to and stabilizing factor VIII in circulation
  • Maintaining adhesion and spreading of endothelial cells
  • Maintaining the integrity of the blood vessels
  • Maintaining normal menstrual bleeding

Clotting Mechanism in the Presence of vWF

Now that we know what vWF is and what it does, let’s take a closer look at its role in the clotting process. When a blood vessel is damaged, several different processes are set into motion to stop the bleeding. One of these processes involves the formation of a platelet plug, in which platelets clump together at the site of injury to form a plug that helps to seal the edges of the wound. This process is triggered when the vWF binds to the exposed collagen in the damaged blood vessel, causing the platelets to stick to the site of the injury and to each other.

Importance of vWF in Factor VIII Regulation

One of the most critical functions of vWF in the body is its role in regulating factor VIII, which is another clotting factor that is essential for normal hemostasis. Factor VIII is highly sensitive to proteolysis, meaning that it’s quickly broken down when it’s exposed to enzymes in the blood. However, when it’s bound to vWF, factor VIII is stabilized and protected from degradation. In addition, vWF helps to transport factor VIII to the site of an injury, where it can play its role in clotting.

What Happens When vWF Is Deficient?

Given the essential role that the von Willebrand factor plays in our bodies, it should come as no surprise that a deficiency in vWF can have significant consequences. Some of the symptoms associated with vWF deficiency, also known as von Willebrand disease (vWD), include:

  • Easy bruising and bleeding that is difficult to stop
  • Frequent and heavy nosebleeds
  • Heavy menstrual bleeding in women
  • Bleeding after dental procedures or surgery
  • Bleeding into the joints, leading to pain and swelling

Categorization of von Willebrand Disease

There are several different types of vWD, each of which is related to a different underlying genetic mutation. Some types of vWD are mild, with minor bleeding symptoms, while others are severe and can be life-threatening. The type of vWD that a person has will determine the appropriate treatment and management approach.

Diagnosis and Treatment of vWD

If a healthcare professional suspects that you have vWD, there are several different diagnostic tests that can be used to confirm a diagnosis. These include:

  • Bleeding time tests
  • Platelet function tests
  • vWF antigen levels and activity tests
  • Factor VIII levels and activity tests
  • Molecular testing to look for genetic mutations

Treatment Approach to vWD

Once a diagnosis of vWD has been confirmed, there are a few different treatment approaches that may be recommended. Some people with mild forms of the condition may not need any treatment at all, while others with more severe symptoms may require medication, including:

  • Desmopressin (DDAVP)
  • vWF concentrates
  • Factor VIII concentrates

The Role of vWF in Cardiovascular Disease

One of the most critical consequences of vWF deficiency is an increased risk of cardiovascular disease. People with vWD are more likely to experience thrombotic events, such as deep vein thrombosis or pulmonary embolism, and may also have an increased risk of heart attacks and strokes. However, even for people without vWD, vWF levels may play a critical role in their overall health. In fact, high levels of vWF are associated with an increased risk of atherosclerosis, coronary artery disease, and other cardiovascular problems, making it an essential biomarker for clinicians to measure in their patients.

Testing for vWF and Cardiovascular Disease

Given the critical role that vWF levels play in cardiovascular disease risk, there has been substantial interest in developing tests that can measure these levels accurately. Some of the most well-known tests for vWF levels include:

  • ELISA (enzyme-linked immunosorbent assay)
  • Assays using vWF-specific antibodies
  • Functional assays that measure vWF activity
  • Assays that measure cleavage of the vWF protein


The von Willebrand factor is a fundamental component of the blood that plays a critical role in both hemostasis and thrombosis. This complex protein is involved in a range of different functions, from helping platelets stick together at the site of an injury to regulating the activity of factor VIII, another essential clotting factor. When vWF is deficient, it can lead to significant bleeding symptoms, and may also increase the risk of cardiovascular disease. As such, understanding the role of vWF in the body is crucial for clinicians, researchers, and anyone interested in maintaining optimal health.


Here are some of the most common questions people have about the von Willebrand factor:

What happens if you have too much vWF?

While a deficiency in vWF is associated with bleeding symptoms, having too much vWF can also be problematic. High levels of vWF are associated with an increased risk of atherosclerosis, thrombosis, heart attacks, and stroke, making it essential to monitor vWF levels in patients with cardiovascular risk factors.

What causes von Willebrand disease?

Von Willebrand disease is caused by a genetic mutation that affects the way the vWF protein is produced or function in the body. There are three main types of vWD, each of which is caused by a different mutation, and each of which affects vWF levels and activity in different ways.

How is von Willebrand disease treated?

For people with mild forms of vWD, no treatment may be needed. However, for people with more severe bleeding symptoms, medication may be recommended, including desmopressin, vWF concentrates, or Factor VIII concentrates. In some cases, patients may also need to undergo surgical procedures to control bleeding or to manage joint damage caused by repeated bleeding into the joints.

How is vWF measured?

There are several different tests that can be used to measure vWF levels, including ELISA, functional assays, and assays that measure the cleavage of the vWF protein. These tests are typically done in specialized laboratories and are used to help diagnose vWD, monitor response to treatment, and assess cardiovascular disease risk.

Can you prevent vWD?

Since von Willebrand disease is caused by a genetic mutation, it’s not possible to prevent the condition entirely. However, people with vWD can take steps to reduce their risk of bleeding symptoms by avoiding medications like aspirin and nonsteroidal anti-inflammatory drugs (NSAIDs), being cautious when participating in activities that could result in injury or trauma, and seeking prompt medical attention if they experience any symptoms of bleeding or bruising.

Does von Willebrand disease affect both men and women?

Yes, von Willebrand disease affects both men and women. Women with vWD may experience heavy menstrual bleeding, which can lead to anemia, while men may be more prone to bleeding after dental procedures or surgery.


1. Nichols WL, Hultin MB, James AH, et al. von Willebrand Disease (VWD): Evidence-Based Diagnosis and Management Guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel Report (USA). Haemophilia. 2008 Jul;14(3):171-232.

2. Geddings JE and Mackman N. Tumor-derived tissue factor-positive microparticles and venous thrombosis in cancer patients. Blood. 2013 Jul 25;122(4):1873-80.

3. Substance Abuse and Mental Health Services Administration. Advisory: Nonsteroidal anti-inflammatory drugs and increased risk of bleeding. 2015.

Leave a Reply

Your email address will not be published. Required fields are marked *